| [1] |
Eccles SA, Aboagye EO, Ali S, et al. Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer[J]. Breast Cancer Res,2013,15(5):R92.
|
| [2] |
Arnold M, Karim-Kos HE, Coebergh JW, et al. Recent trends in incidence of five common cancers in 26 European countries since 1988:Analysis of the European Cancer Observatory[J]. Eur J Cancer,2015,51(9):1164-1187.
|
| [3] |
Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States[J]. Cancer Res,2014,74(11):2913-2921.
|
| [4] |
Walsh MF, Nathanson KL, Couch FJ, et al. Genomic biomarkers for breast cancer risk[J].Adv Exp Med Biol,2016,882:1-32.
|
| [5] |
Fischer C, Kuchenbäcker K, Engel C, et al. Evaluating the performance of the breast cancer genetic risk models BOADICEA,IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium[J]. J Med Genet,2013,50(6):360-367.
|
| [6] |
Colditz GA, Bohlke K. Priorities for the primary prevention of breast cancer[J]. CA Cancer J Clin,2014,64(3):186-194.
|
| [7] |
Hulka BS, Moorman PG. Breast cancer: hormones and other risk factors[J]. Maturitas,2008,61(1-2):203-213.
|
| [8] |
van den Brandt PA, Spiegelman D, Yaun SS, et al. Pooled analysis of prospective cohort studies on height, weight and breast cancer risk[J].Am J Epidemiol,2000,152(6):514-527.
|
| [9] |
Santen RJ,Boyd NF,Chlebowski RT,et al. Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model[J]. Endocr Relat Cancer,2007,14(2):169-187.
|
| [10] |
Clemons M, Goss P.Estrogen and the risk of breast cancer[J]. N Engl J Med,2001,344(4):276-285.
|
| [11] |
Lin Y, Wang C, Zhong Y, et al. Striking life events associated with primary breast cancer susceptibility in women: a meta-analysis study[J].J Exp Clin Cancer Res,2013,32(1):53.
|
| [12] |
Engel GL. The need for a new medical model: a challenge for biomedicine[J]. Science,1977,196(4286):129-136.
|
| [13] |
Seyednoori T, Pakseresht S, Roushan Z. Risk of developing breast cancer by utilizing Gail model[J]. Women Health,2012,52(4):391-402.
|
| [14] |
Quante AS, Whittemore AS, Shriver T, et al. Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance[J].Breast Cancer Res,2012,14(6):R144.
|
| [15] |
徐雅莉,孙强,单广良,等, 中国女性乳腺癌发病相关危险因素:病例对照研究[J].协和医学杂志,2011,2(1):7-14.
|
| [16] |
Evans DG, Graham J, O'Connell S,et al. Familial breast cancer:summary of updated NICE guidance[J]. BMJ,2013,346:f3829.
|
| [17] |
Huo CW, Chew GL, Britt KL, et al. Mammographic density-a review on the current understanding of its association with breast cancer[J].Breast Cancer Res Treat,2014,144(3):479-502.
|
| [18] |
Cummings SR,Tice JA,Bauer S, et al. Prevention of breast cancer in postmenopausal women: approaches to estimatingand reducing risk[J].J Natl Cancer Inst,2009,101(6):384-398.
|
| [19] |
McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis[J]. Cancer Epidemiol Biomarkers Prev,2006,15(6):1159-1169.
|
| [20] |
Tice JA, Cummings SR, Ziv E, et al. Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population[J]. Breast Cancer Res Treat,2005,94(2):115-122.
|
| [21] |
Barlow WE, White E, Ballard-Barbash R, et al. Prospective breast cancer risk prediction model for women undergoing screening mammography[J]. J Natl Cancer Inst,2006,98(17):1204-1214.
|
| [22] |
Chen J, Pee D, Ayyagari R, et al. Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density[J]. J Natl Cancer Inst,2006,98(17):1215-1226.
|
| [23] |
Tice JA, Cummings SR, Smith-Bindman R, et al. Using clinical factors and mammographic breast density to estimate breast cancer risk:development and validation of a new predictive model[J]. Ann Intern Med,2008,148(5):337-347.
|
| [24] |
Vachon CM, Fowler EE, Tiffenberg G, et al. Comparison of percent density from raw and processed full-field digital mammography data[J]. Breast Cancer Res,2013,15(1):R1.
|
| [25] |
Keller BM, Chen J, Conant EF, et al.Breast density and parenchymal texture measures as potential risk factors for estrogen-receptor positive breast cancer[J]. Proc SPIE Int Soc Opt Eng,2014,9035:90351D.
|
| [26] |
Michailidou K,Hall P,Gonzalez-Neira A,et al.Large-scale genotyping identifies 41 new loci associated with breast cancer risk[J]. Nat Genet,2013,45(4):353-361.
|
| [27] |
Brentnall AR, Evans DG, Cuzick J. Distribution of breast cancer risk from SNPs and classical risk factors in women of routine screening age in the UK[J]. Br J Cancer,2014,110(3):827-828.
|
| [28] |
Purrington KS, Slettedahl S, Bolla MK, et al. Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade[J]. Hum Mol Genet,2014,23(22):6034-6046.
|
| [29] |
Purrington KS, Slager S, Eccles D, et al. Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer[J]. Carcinogenesis,2014,35(5):1012-1019.
|
| [30] |
Jones ME, Schoemaker MJ, Rae M, et al. Reproducibility of estradiol and testosterone levels in postmenopausal women over 5 years: results from the breakthrough generations study[J]. Am J Epidemiol,2014,179(9):1128-1133.
|
| [31] |
Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies[J]. Lancet,2008,371(9612):569-578.
|
| [32] |
Harvie M, Howell A, Vierkant RA, et al. Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women' s health study[J]. Cancer Epidemiol Biomarkers Prev,2005,14(3):656-661.
|
| [33] |
Prentice RL, Caan B, Chlebowski RT, et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women' s Health Initiative Randomized Controlled Dietary Modification Trial[J]. JAMA,2006,295(6):629-642.
|
| [34] |
Pierce JP,Natarajan L,Caan BJ,et al. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living(WHEL) randomized trial[J]. JAMA 2007,298:289-298.
|
| [35] |
Jung S, Spiegelman D, Baglietto L, et al. Fruit and vegetable intake and risk of breast cancer by hormone receptor status[J]. J Natl Cancer Inst 2013,105(3):219-236.
|
| [36] |
Eliassen AH, Hendrickson SJ, Brinton LA, et al. Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies[J]. J Natl Cancer Inst,2012,104(24):1905-1916.
|
| [37] |
Catsburg C, Miller AB, Rohan TE. Adherence to cancer prevention guidelines and risk of breast cancer[J]. Int J Cancer,2014,135(10):2444-2252.
|
| [38] |
Thomson CA, McCullough ML, Wertheim BC, et al. Nutrition and physical activity cancer prevention guidelines, cancer risk, and mortality in the women' s health initiative [J]. Cancer Prev Res(Phila),2014,7(1):42-53.
|
| [39] |
Lynch BM, Neilson HK, Friedenreich CM. Physical activity and breast cancer prevention[J]. Recent Results Cancer Res,2011,186:13-42.
|
| [40] |
Chen WY, Rosner B, Hankinson SE, et al. Moderate alcohol consumption during adult life,drinking patterns,and breast cancer risk[J]. JAMA,2011,306(17):1884-1890.
|
| [41] |
Ferrari P, Licaj I, Muller DC, et al. Lifetime alcohol use and overall and cause-specific mortality in the European Prospective Investigation into Cancer and nutrition (EPIC) study[J]. BMJ Open,2014,4(7):e005245.
|
| [42] |
Beattie MS, Costantino JP, Cummings SR, et al. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1) [J].J Natl Cancer Inst,2006,98(2):110-115.
|
| [43] |
Vogel VG, Costantino JP, Wickerham DL, et al. Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer[J].Cancer Prev Res (Phila),2010,3(6):696-706.
|
| [44] |
Goss PE, Ingle JN, Alés-Martínez JE, et al. Exemestane for breastcancer prevention in postmenopausal women [J]. N Engl J Med,2011,364(25):2381-2391.
|
| [45] |
Cuzick J, Sestak I, Forbes JF,et al. Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial[J].Lancet,2014,383(9922):1041-1048.
|
| [46] |
van Dijk S, van Roosmalen MS, Otten W, et al. Decision making regarding prophylactic mastectomy: stability of preferences and the impact of anticipated feelings of regret [J]. J Clin Oncol,2008,26(14):2358-2363.
|